Ajanta Pharma Ltd

Ajanta Pharma Limited provided a written transcript of its earnings call held on 30th October 2026, as required by SEBI regulations. The transcript is available on the company's website at the specified link. The document does not include specific financial results, operational updates, or management commentary from the call. It serves as a formal disclosure to stakeholders, confirming the availability of the earnings call transcript for reference. No details about the discussion or performance metrics were included in this filing.

The tone is neutral as the document only confirms the availability of the transcript without providing specific content or commentary from the call.